Evonik, has announced a partnership with ST Pharm, a South Korea-based CDMO specialising in active pharmaceutical ingredients (APIs) for gene therapy. This collaboration aims to streamline RNA and nucleic acid therapeutic services, enabling pharmaceutical companies to reduce complexity and speed
ST Pharm and Quantoom Biosciences have announced an extended collaboration to advance the development and manufacturing of RNA-based vaccines and therapeutics. This partnership integrates the complementary strengths of both companies to enhance the global supply of critical RNA manufacturing technologies.
ST PHARM is a Manufacturer/Innovator, CMO/CDMO, Contract Research Organisation (CRO) company operating in the pharmaceutical industry. ST Pharm has been offering excellent custom manufacturing services of oligonucleotides and small molecule APIs CDMO to meet clients’ high expectation for their use
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
